SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress

Antioxidants and Redox Signaling

Volumn 8, Issue 7-8, 2006, Pages 1217-1225

  Martin, Florent M ^a   Bydlon, Gabriela ^a,b   Friedman, Jeffrey S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; EUK 189; FREE RADICAL; MANGANESE CHLORIDE; MANGANESE DERIVATIVE; MANGANESE SALEN CHLORIDE; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CELL DAMAGE; CELL MATURATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; ERYTHROCYTE LIFESPAN; HEMATOCRIT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRON METABOLISM; IRON OVERLOAD; METABOLISM; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIDEROBLASTIC ANEMIA;

ANEMIA, SIDEROBLASTIC; ANIMALS; ANTIOXIDANTS; ERYTHROCYTES; HUMANS; MANGANESE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

ANIMALIA;

EID: 33746783738     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1217     Document Type: Review

References (55)

1. Alcindor T and Bridges KR. Sideroblastic anaemias. Br J Haematol 116: 733-743, 2002.
2. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, and Koeller DM. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8: 743-749, 1999.
3. Al-Maghrebi M, Fridovich I, and Benov L. Manganese supplementation relieves the phenotypic deficits seen in superoxide-dismutase-null Escherichia coli. Arch Biochem Biophys 402: 104-109, 2002.
4. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, and Doctrow SR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 284: 215-221, 1998.
5. Beck EA, Ziegler G, Schmid R, and Ludin H. Reversible sideroblastic anemia caused by chloramphenicol. Acta Haematol 38: 1-10, 1967.
6. Bessho F, Ohnishi H, Tabuchi K, Kobayashi M, and Hayashi Y. Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome. Br J Haematol 105: 149-154, 1999.
7. Carlsson LM, Jonsson J, Edlund T, and Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A 92: 6264-6268, 1995.
8. Cotter PD, Rucknagel DL, and Bishop DF. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood 84: 3915-3924, 1994.
9. Devadas S, Zaritskaya L, Rhee SG, Oberley L, and Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med 195: 59-70, 2002.
10. Dobson J. Magnetic iron compounds in neurological disorders. Ann N Y Acad Sci 1012: 183-192, 2004.
11. Drake SK, Bourdon E, Wehr NB, Levine RL, Backlund PS, Yergey AL, and Rouault TA. Numerous proteins in mammalian cells are prone to iron-dependent oxidation and proteasomal degradation. Dev Neurosci 24: 114-124, 2002.
12. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 39: 270-281, 2002.
13. Fleming MD, Campagna DR, Haslett JN, Trenor CC 3rd, and Andrews NC. A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice. Genes Dev 15: 652-657, 2001.
14. Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, Boyd A, Doctrow SR, and Burakoff SJ. SOD2-deficiency anemia: Protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 104: 2565-2573, 2004.
15. Friedman JS, Rebel VI, Derby R, Bell K, Huang TT, Kuypers FA, Epstein CJ, and Burakoff SJ. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 193: 925-934, 2001.
16. Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, Aul C, and Schneider W. Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 90: 4961-4972, 1997.
17. Gianello P, Saliez A, Bufkens X, Pettinger R, Misseleyn D, Hori S, and Malfroy B. EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage. Transplantation 62: 1664-1666, 1996.
18. HaMai D and Bondy SC. Pro- or anti-oxidant manganese: A suggested mechanism for reconciliation. Neurochem Int 44: 223-229, 2004.
19. Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doctrow SR, Harry J, and Melov S. Endogenous mitochondrial oxidative stress: Neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 88: 657-667, 2004.
20. Hoffmann-Fezer G, Maschke H, Zeitler HJ, Gais P, Heger W, Ellwart J, and Thierfelder S. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann Hematol 63: 214-217, 1991.
21. Hussain S and Ali SF. Manganese scavenges superoxide and hydroxyl radicals: An in vitro study in rats. Neurosci Lett 261: 21-24, 1999.
22. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
23. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, and Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273: 6297-6302, 1998.
24. Keyhani M, Giuliani D, Giuliani ER, and Morse BS. Erythropoiesis in pyridoxine deficient mice. Proc Soc Exp Biol Med 146: 114-119, 1974.
25. Kurata M, Suzuki M, and Agar NS. Antioxidant systems and erythrocyte life-span in mammals. Comp Biochem Physiol B 106: 477-487, 1993.
26. Lamola AA, Piomelli S, Poh-Fitzpatrick MG, Yamane T, and Harber LC. Erythropoietic protoporphyria and lead intoxication: The molecular basis for difference in cutaneous photosensitivity, II: Different binding of erythrocyte protoporphyrin to hemoglobin. J Clin Invest 56: 1528-1535, 1975.
27. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, and Matzuk MM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93: 9782-9787, 1996.
28. Lee JM, Chan K, Kan YW, and Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci U S A 101: 9751-9756, 2004.
29. Lee TH, Kim SU, Yu SL, Kim SH, Park do S, Moon HB, Dho SH, Kwon KS, Kwon HJ, Han YH, Jeong S, Kang SW, Shin HS, Lee KK, Rhee SG, and Yu DY. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038, 2003.
30. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
31. Louis TA, Lavori PW, Bailar JC 3rd, and Polansky, M. Crossover and self-controlled designs in clinical research. N Engl J Med 310: 24-31, 1984.
32. Lux SE, John KM, and Karnovsky MJ. Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. J Clin Invest 58: 955-963, 1976.
33. Lyons BL, Lynes MA, Burzenski L, Joliat MJ, Hadjout N, and Shultz LD. Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice. Exp Hematol 31: 234-243, 2003.
34. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79: 7634-7638, 1982.
35. Martin FM, Bydlon G, Welsh ML, and Friedman JS. A method for rapid mouse siderocyte enrichment. Exp Hematol 33: 1493-1499, 2005.
36. May A and Fitzsimons E. Sideroblastic anaemia. Baillieres Clin Haematol 7: 851-879, 1994.
37. McCord JM and Fridovich I. Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969.
38. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, and Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96: 846-851, 1999.
39. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, Wallace DC, and Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21: 8348-8353, 2001.
40. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, and Lithgow GJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science 289: 1567-1569, 2000.
41. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, and Wallace DC. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 18: 159-163, 1998.
42. Musleh W, Bruce A, Malfroy B, and Baudry M. Effects of EUK-8, a synthetic catalytic superoxide scavenger, on hypoxia-and acidosis-induced damage in hippocampal slices. Neuropharmacology 33: 929-934, 1994.
43. Napier I, Ponka P, and Richardson DR. Iron trafficking in the mitochondrion: Novel pathways revealed by disease. Blood 105: 1867-1874, 2005.
44. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT, Hoffman R, and Marsh JC. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95: 976-984, 1979.
45. Piscator M. Manganese. In: Friberg L, Norberg GF, Vouk VB (Eds). Handbook of the Toxicology of Metals. Amsterdam: Elsevier Science Publishers, 1986, pp 485-499.
46. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, and Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13: 43-47, 1996.
47. Rosse WF. Quantitative immunology of immune hemolytic anemia, II: The relationship of cell bound antibody to hemolysis and the effect of treatment. J Clin Invest 50: 734-743, 1971.
48. Rouault TA and Tong WH. Opinion: Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol 6: 345-351, 2005.
49. Sen G, Mukhopadhyay R, Ghosal J, and Biswas T. Oxidative damage of erythrocytes: A possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters. Ann Hematol 80: 32-37, 2001.
50. Sharp RA, Lowe JG, and Johnston RN. Anti-tuberculous drugs and sideroblastic anaemia. Br J Clin Pract 44: 706-707, 1990.
51. Smetana K, Cermak J, Jiraskova I, and Malaskova V. Nucleolar abnormalities: A defect of the nucleolar preribosome assembly in ringed sideroblasts in refractory anaemia with ringed sideroblasts (RARS) of myelodysplastic syndrome (MDS): An electron microscopic study. Sb Lek 104: 199-207, 2003.
52. Sziraki I, Rauhala P, and Chiueh CC. Novel protective effect of manganese against ferrous citrate-induced lipid peroxidation and nigrostriatal neurodegeneration in vivo. Brain Res 698: 285-287, 1995.
53. Weisiger RA and Fridovich I. Mitochondrial superoxide dismutase: Site of synthesis and intramitochondrial localization. J Biol Chem 248: 4793-4796, 1973.
54. Wickramasinghe SN, Fulker MJ, Losowsky MS, and Hall R. Microspectrophotometric and electron microscopic studies of bone marrow in hereditary sideroblastic anaemia. Acta Haematol 45: 236-244, 1971.
55. Yunis AA and Salem Z. Drug-induced mitochondrial damage and sideroblastic change. Clin Haematol 9: 607-619, 1980.